Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: A retrospective analysis

Anesthesiology

Volumn 124, Issue 1, 2016, Pages 69-79

  Wigmore, Timothy J ^a   Mohammed, Kabir ^b   Jhanji, Shaman ^a  

^a Unit of Critical Care   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

ADULT; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER SURGERY; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; INHALATION ANESTHESIA; INTERMETHOD COMPARISON; INTRAVENOUS ANESTHESIA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; ENGLAND; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; NEOPLASMS; STATISTICS AND NUMERICAL DATA;

ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONDON; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84951905488     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000936     Document Type: Article

References (35)

1. Ferlay JI, Soerjomataram M, Ervik R, Dikshit S, Eser C, Mathers M, Rebelo M, Parkin DM, Forman D, Bray F, GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. 2013 Lyon, France International Agency for Research on Cancer. Available at: http://globocan.iarc.fr. Accessed February 10, 2015
2. NHS treated cancer patients receiving major surgical resections 2004-2006 National Cancer Intelligence Network. 2011. Available at: http://www.ncin.org.uk/publications/data-briefings/major-resection. Accessed October 23, 214
3. van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, Coffey JC, van Egmond M, The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg 2009 249 727 34
4. Eschwège P, Dumas F, Blanchet P, Le Maire V, Benoit G, Jardin A, Lacour B, Loric S, Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995 346 1528 30
5. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S, Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000 232 58 65
6. Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M, Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 2011 29 1547 55
7. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P, Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: A systematic review. Br J Cancer 2010 102 1327 34
8. Da Costa ML, Redmond HP, Finnegan N, Flynn M, Bouchier-Hayes D, Laparotomy and laparoscopy differentially accelerate experimental flank tumour growth. Br J Surg 1998 85 1439 42
9. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ, Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: A retrospective analysis. A nesthesiology 2008 109 180 7
10. Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR, Sessler DI, ANZCA Trials Group Investigators Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: Randomised trial. BMJ 2011 342 d1491
11. Juneja R, Opioids and cancer recurrence. Curr Opin Support Palliat Care 2014 8 91 101
12. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S, Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: Mediating mechanisms and prophylactic measures. Anesth Analg 2003 97 1331 9
13. Buckley A, Quaid MS, Johnson P, Buggy D, Serum from women undergoing breast cancer surgery, randomized to propofol vs paravertebral anaesthetic technique, maintain natural killer cell anti-tumour activity compared with sevoflurane/opioid technique. Eur J Anaesthesiol 2014 31 2
14. Huang H, Benzonana LL, Zhao H, Watts HR, Perry NJ, Bevan C, Brown R, Ma D, Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer 2014 111 1338 49
15. Luo X, Zhao H, Hennah L, Ning J, Liu J, Tu H, Ma D, Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br J Anaesth 2014 114 831 9
16. Rohwer N, Lobitz S, Daskalow K, Jöns T, Vieth M, Schlag PM, Kemmner W, Wiedenmann B, Cramer T, Höcker M, HIF-1α determines the metastatic potential of gastric cancer cells. Br J Cancer 2009 100 772 81
17. Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S, HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 2010 176 2292 301
18. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW, Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999 59 5830 5
19. th National Audit Project (NAP5) on accidental awareness during general anaesthesia: Summary of main findings and risk factors. Br J Anaesth 2014 113 549 59
20. Benzonana LL, Perry NJ, Watts HR, Yang B, Perry IA, Coombes C, Takata M, Ma D, Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. A nesthesiology 2013 119 593 605
21. The use of routine preoperative tests for elective surgery. NICE clinical guideline 3: National Institute for Health and Clinical Excellence. 2003
22. Mansi JL, Gogas H, Bliss JM, Gazet JC, Berger U, Coombes RC, Outcome of primary-breast-cancer patients with micrometastases: A long-term follow-up study. Lancet 1999 354 197 202
23. Tartter PI, Steinberg B, Barron DM, Martinelli G, The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 1987 122 1264 8
24. Brittenden J, Heys SD, Ross J, Eremin O, Natural killer cells and cancer. Cancer 1996 77 1226 43
25. Amato A, Pescatori M, Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006 CD005033
26. Roche-Nagle G, Connolly EM, Eng M, Bouchier-Hayes DJ, Harmey JH, Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer 2004 91 359 65
27. Li QF, Wang XR, Yang YW, Su DS, Up-regulation of hypoxia inducible factor 1α by isoflurane in Hep3B cells. A nesthesiology 2006 105 1211 9
28. Semenza GL, HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 2013 123 3664 71
29. Semenza GL, Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012 33 207 14
30. Shi QY, Zhang SJ, Liu L, Chen QS, Yu LN, Zhang FJ, Yan M, Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro. Br J Anaesth 2015 114 825 30
31. Yeh CH, Cho W, So EC, Chu CC, Lin MC, Wang JJ, Hsing CH, Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1α expression. Br J Anaesth 2011 106 590 9
32. Tanaka T, Takabuchi S, Nishi K, Oda S, Wakamatsu T, Daijo H, Fukuda K, Hirota K, The intravenous anesthetic propofol inhibits lipopolysaccharide-induced hypoxia-inducible factor 1 activation and suppresses the glucose metabolism in macrophages. J Anesth 2010 24 54 60
33. Luo X, Zhao H, Hennah L, Ning J, Liu J, Tu H, Ma D, Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br J Anesth 2015 114 831 9
34. Clayton PE, Banerjee I, Murray PG, Renehan AG, Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 2011 7 11 24
35. Enlund M, Berglund A, Andreasson K, Cicek C, Enlund A, Bergkvist L, The choice of anaesthetic-sevoflurane or propofol-and outcome from cancer surgery: A retrospective analysis. Ups J Med Sci 2014 119 251 61